EligibleTrials
Drugs & treatments › EBNK-001 + IL-15 + Pembrolizumab

EBNK-001 + IL-15 + Pembrolizumab: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1
Recruiting trials
15
Conditions studied
0
US states with sites
1
Countries

Phase breakdown

Phase 1 1 Phase 2 1

Conditions being studied

ConditionTrials
Bladder Cancer1
Breast Cancer (Locally Advanced or Metastatic)1
Cancer1
Colorectal Cancer1
Esophageal Cancer1
Glioblastoma1
Kidney Cancer1
Leukaemia1
Liver Cancer (Primary and Metastatic)1
Lung Cancer (Diagnosis)1
Melanoma1
Melanoma (Skin Cancer)1
Non-Melanoma Skin Cancer1
Ovarian Cancer1
Pancreatic Cancer Metastatic1

Recruiting trials involving EBNK-001 + IL-15 + Pembrolizumab

Common questions

How many recruiting trials involve EBNK-001 + IL-15 + Pembrolizumab?

1 recruiting trial across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.